Introduction {#Sec1}
============

The idea that the depletion of an intracellular calcium store activates a calcium influx pathway, which serves to replete the store was introduced in the 1980s \[[@CR30], [@CR36]\]. The phenomenon was termed store-operated or capacitative calcium influx \[[@CR30], [@CR36]\]. Since that time, store-operated calcium influx has been characterised in numerous cell types \[[@CR29], [@CR30]\]. Considerable advances were made in the electrophysiological characterization of this process \[[@CR17]\] (reviewed in \[[@CR29]\]). A number of pathways involved in the regulation of store-operated calcium influx were described \[[@CR2], [@CR10], [@CR11], [@CR16], [@CR22], [@CR41], [@CR49]\], and some elegant theories were put forward to explain the phenomenon \[[@CR4], [@CR18]\]. However, until very recently, neither the calcium sensor in the ER lumen nor the channel responsible for calcium influx were known. In the last few years, there has been remarkable progress in the characterization of store-operated calcium influx. Stromal interacting molecule one (STIM1) was originally characterized as a plasma membrane protein with the properties of a tumor suppressor \[[@CR26], [@CR32], [@CR39], [@CR45]\]. Recently, two independent studies using a siRNA screen discovered and characterized the role of STIM1 in activation of store-operated calcium influx \[[@CR20], [@CR38]\]. It is now accepted that STIM1 is the calcium sensor in the ER, and translocation of STIM1 to the sub-plasmalemmal region followed by its interaction with calcium influx channels are the processes that mediate capacitative calcium influx. STIM2 could also play an important role particularly in establishing basal \[Ca^2+^\] in ER and cytosol \[[@CR5]\]. ORAI1 (also known as CRACM1) was found to function as an essential component of the Ca^2+^ entry channel \[[@CR8], [@CR35], [@CR44], [@CR48]\], and the formation of the functional units of store-operated Ca^2+^ entry was recently characterized by Luik et al. \[[@CR21]\]. In their study, depletion of the ER calcium store induced translocation of STIM1 to sub-plasmalemmal puncta, which co-localized with ORAI1 clusters and regions of preferred calcium influx \[[@CR21]\]. TRP channels \[[@CR33]\] have been also considered as mediators of store-operated calcium influx \[[@CR47]\]. The role of this channel type in store-operated calcium influx is currently debated \[[@CR37]\].

The process by which STIM1 translocates to the plasma membrane is only partially characterized. The calcium sensor (the relatively low affinity EF hand domain) is localized to the part of the STIM1 molecule which projects into the ER lumen. After the decrease of ER calcium, STIM1 molecules form oligomers and thereafter move towards the plasma membrane to form sub-plasmalemmal puncta \[[@CR19]\]. The observation that strands of ER could translocate towards the plasma membrane \[[@CR46]\] suggests active (i.e. ATP-dependent) molecular motoring. The recently reported insertion of STIM1 into the plasma membrane by a specialized form of secretion \[[@CR13]\] also suggests an ATP-dependent process (at least at the stage of vesicle recruitment \[[@CR7]\]).

Sub-plasmalemmal mitochondria have been shown to effectively accumulate and regulate calcium entering the cell via various types of plasma membrane channels \[[@CR16], [@CR25], [@CR31]\]. Several mechanisms of mitochondrial regulation of calcium influx have been described \[[@CR1], [@CR28], [@CR34]\].

A number of investigations indicated that ATP depletion resulted in the inhibition of store-operated calcium entry \[[@CR3], [@CR9], [@CR23]\]. We confirmed this observation in the current study. We hypothesized that the reason for such inhibition could be suppression of an active transport process that transfers STIM1 to sub-plasmalemmal region, and we therefore decided to investigate the translocation of STIM1 under conditions of ATP depletion. To our surprise, ATP depletion actually induced STIM1 translocation and formation of sub-plasmalemmal puncta. This process was initiated and developed at very low ATP levels and substantially depleted PI(4,5)P~2~. In the second part of the study we characterized the process of STIM1 re-translocation (restoration of diffuse STIM1 distribution after repletion of calcium stores) and observed that it can also occur in an ATP-independent fashion. Finally, we observed that ATP depletion triggers the formation of STIM1--ORAI1 clusters.

Materials and methods {#Sec2}
=====================

Plasmids {#Sec3}
--------

STIM1-EYFP/mCherry-ORAI1 plasmid construction: HeLa cell total RNA was extracted from approximately 100 × 10^6^ cells using Trizol reagent (Invitrogen, The Netherlands) and used as a template for reverse transcription using Improm-II reverse transcriptase (Promega, Southampton, UK) and oligo-dT~(15)~ priming. The resulting single stranded cDNA was then used as a template in PCR reactions to amplify full-length human STIM1 or ORAI1 using specific primers (below) containing restriction endonuclease sites to permit subsequent sub-cloning into the C-terminally tagging pEYFP-N1 vector (Clontech, Palo Alto, USA) or into the N-terminally tagging mCherry-C1 vector (gift from Roger Y. Tsien, University of California at San Diego) correspondingly. The primers for the STIM1 were based on the human sequence with GenBank accession number: NM_003156. The primers for ORAI1 were based on the human sequence with GenBank accession number: BC015369. All constructs were verified by automated sequencing in both directions (The Sequencing Service, University of Dundee, Dundee, UK).

Primers: STIM1 Sense (HindIII) 5′- ACTGAAGCTTATGGATGTATGCGTCCGTCTTGCC - 3′STIM1 Antisense (SacII) 5′- ACTGCCGCGGCTTCTTAAGAGGCTTCTTAAAG - 3′ORAI1 Sense (*XhoI*): 5′- ATATCTCGAGGAATGCATCCGGAGCCCGCCCCG - 3′ORAI1 Antisense (*SacII*): 5′- ATATCCGCGGCTAGGCATAGTGGCTGCCGGG - 3′.

The plasmid for ER targeted Cameleon (D1ER) was a gift from Roger Y. Tsien (University of California at San Diego). Properties of this probe for studies of ER calcium are described in \[[@CR27]\].

Replication-deficient adenoviruses containing cytosolic luciferase (Ad-CMV-Luc) were purchased from Vector Biolabs (Philadelphia, PA, USA).
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\begin{document}$${\text{C}}_{\delta {\text{1}}} $$\end{document}$ cloned into eCFP-C1 was a gift from Dr. M. Katan (Imperial Cancer Research Fund, London, UK).

Chemicals and reagents {#Sec4}
----------------------

Cell culture reagents were purchased from Invitrogen (Paisley, UK), except for RPMI-1640 which was purchased from Cambrex (Nottingham, UK) and GeneJuice which was purchased from Merck Biosciences (Darmstadt, Germany). Thapsigargin and *N*,*N*,*N*′,*N*′-Tetrakis(2-pyridylmethyl)ethylenediamine (TPEN) were purchased from Calbiochem (San Diego, CA, US). Fura-2 AM and Fura Red AM were from Invitrogen/Molecular Probes. All other chemicals were purchased from Sigma (Gillingham, UK).

Cell culture and transfection {#Sec5}
-----------------------------

The RAMA37 cell line was maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 1% Penicillin and Streptomycin, [l]{.smallcaps}-Glutamine, Hydrocortisone (50 ng/ml), and insulin (50 ng/ml). The PANC1 cell line was maintained in RPMI-1640 containing 10% FBS and 1% Penicillin and Streptomycin. HeLa cells were maintained in DMEM supplemented with 10% FBS, 1% Penicillin and Streptomycin and 1% MEM nonessential amino acids.

Before transfection, cells were grown to 80--90% confluency in 35-mm Petri dishes with glass bottoms (MatTek, Ashland, MA, USA). Plasmids and transfection reagents were added directly to Petri dishes. Transfections of RAMA37 cell and PANC1 cells were carried out with 2 or 3 μg of plasmid of interest and Lipofectamine 2000 according to the manufacturer's (Invitrogen) protocol. For transfection of HeLa cells, we used 3 μg of plasmid(s) of interest supplemented with 8 μl GeneJuice (Merck Biosciences). For simultaneous transfection with STIM1 and ORAI1 plasmids, 1.5 μg of each plasmid DNA was mixed and supplemented with 8 μl GeneJuice.

Solutions {#Sec6}
---------

The standard extracellular solution used during all experiments contained (in mM): NaCl 140, KCl 4.7, CaCl~2~ 2, MgCl~2~ 1.13, glucose 10, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 10 (pH 7.3). To induce ATP depletion, cells were treated with a solution containing a combination of inhibitors 5 μM Oligomycin (Olig) with 2 mM Iodoacetate (IA) or 5 μM Oligomycin with 10 mM 2-deoxy-[d]{.smallcaps}-glucose (2DOG). In some experiments, where indicated, CaCl~2~ and glucose were omitted from the extracellular solution. All experiments were performed at room temperature. Cells were washed three times in standard extracellular solution and mounted in a perfusion chamber on the stage of an inverted microscope. During experiments, a gravity-fed perfusion system was used to exchange extracellular solution.

Confocal microscopy {#Sec7}
-------------------

Zeiss LSM 510 (Carl Zeiss, Jena, Germany) or Leica AOBS SP2 microscope (Leica Microsystems AG, Wetzlar, Germany) equipped with a ×63 water immersion objective (N.A. 1.2) were used in our experiments. Images of STIM1-EYFP were obtained with 496 nm excitation light (488 nm in experiments conducted on Zeiss LSM 510) and emission fluorescence selected with a 505--550 nm bandpass filter. For excitation of ORAI1-mCherry 594 nm laser line was used. For simultaneous imaging of STIM1-EYFP and ORAI1-mCherry, we used 510--550 and 610--710 nm emission bandpasses, respectively. D1ER was imaged with 405 nm excitation light and 440--500 and 530--650 nm emission bandpass filters for CFP and citrine (YFP), respectively. GFP-PH fluorescence was excited at 488 nm laser line and emission was monitored at 505--550 nm.

Ratiometric calcium measurements were conducted on HeLa cells loaded with 5 μM of Fura-2 AM in the presence of 0.05% Pluronic F-127 for 30 min at room temperature. Leica AOBS SP2 microscope was used in these experiments. Laser lines, 351 and 405 nm, were used to excite the indicator; emission was collected at 430--570 nm. Ratio of Fura-2 fluorescence at 351 and 405 nm was determined. The maximal values of derivative of Fura-2 ratio curve were used to calculate the rates of calcium influx. Differentiation was produced using Origin software. To allow comparison between different groups of measurements, the derivative was normalized by the maximal amplitude of ratio for each individual trace. Calcium measurements in HeLa cells loaded with Fura Red (5 μM of Fura Red AM for 30 min at room temperature) were conducted on Zeiss LSM 510. The probe was excited with 488 nm; emission filter used was LP560. The maximal values of derivative of normalized Fura Red curves (calculated using Origin software) were used to calculate the rates of calcium influx.

Bioluminescence measurements {#Sec8}
----------------------------

Bioluminescent imaging of ATP was carried out using adenoviral construct of cytosol-targeted firefly luciferase Ad-CMV-Luc purchased from Vector Biolabs (Philadelphia, PA 19104, USA). RAMA37 cells were infected by addition of purified virus at approximate viral concentration of 1--7 × 10^7^ PFU/ml of media. After 16--20 h of infection, the medium was changed to the extracellular solution, supplemented with 0.2 mM luciferin, and imaging was performed. Cells in 35-mm glass-bottomed Petri dishes were mounted on the stage of inverted Nikon-Diaphot microscope attached to a Photek HRPCS 325-18 intensified charged couple device (CCD) camera (Photek Ltd, East Sussex, UK). Objective Fluor×20, NA = 0.75 was used for bioluminescence imaging. The imaging system was contained within a dark room. Single photon events were recorded at 1-s intervals. The bioluminescence was than integrated for 60 s, data analysis was performed using Photek Software. The background was subtracted, and integrated photon count (PC) was normalized to the photon count from the cells/clusters before the addition of mitochondria inhibitors. Data were presented as mean value ± SE of mean (for both bioluminescence and fluorescence measurements).

Results {#Sec9}
=======

ATP depletion induced translocation of STIM1 to the plasma membrane {#Sec10}
-------------------------------------------------------------------

Pancreatic and breast cancer cell lines (PANC1 and RAMA37) as well as HeLa cells were utilized in this study. To visualize STIM1 localization the C terminus of STIM1 was tagged with EYFP. Cells were transfected with STIM1-EYFP. In our initial experiments, we observed, for other cell types a well-documented, translocation of STIM1-EYFP and formation of fluorescent sub-plasmalemmal puncta using an inhibitor of the sarcoplasmic/endoplasmic reticulum calcium ATPase thapsigargin (Tg; 5 μM) or a membrane-permeable low affinity calcium buffer *N*,*N*,*N*′,*N*′-Tetrakis(2-pyridylmethyl)ethylenediamine (TPEN) 1 mM (not shown).

The next stage of the project involved depletion of cytosolic ATP. This was achieved by simultaneous inhibition of mitochondrial ATP production with an inhibitor of ATP synthase Oligomycin (Olig) and inhibition of glycolysis by iodoacetate (IA) or 2-deoxyglucose (2DOG). Combined application of Olig (5μM) and 2DOG (10 mM) triggered formation of STIM1-EYFP puncta in RAMA37, PANC1, and HeLa cells (Fig. [1](#Fig1){ref-type="fig"}a*a*--a *c*, *n* = 32 for RAMA37; Fig. [1](#Fig1){ref-type="fig"}c*a*--c*c*, *n* = 3 for PANC1 and Fig. [1](#Fig1){ref-type="fig"}e*a*--e*c*, *n* = 14 for HeLa). A similar phenomenon was observed in these cell types after treatment with 5 μM Olig and 2 mM IA (see Fig. [1](#Fig1){ref-type="fig"}b*a*--b*c*, *n* = 18 for RAMA37; Fig. [1](#Fig1){ref-type="fig"}d*a*--d*c n* = 3 for PANC1 and Fig. [1](#Fig1){ref-type="fig"}f*a*--f*c*, *n* = 10 for HeLa). The formation of STIM1 puncta was also triggered by Rotenone (Rot), the inhibitor of Complex I of the mitochondrial electron transport chain (not shown, *n* = 5 for RAMA37). A substantial delay between application of inhibitors and formation of puncta was observed. The average time for formation of the first resolvable puncta was 773 ± 586 s for Olig/2DOG and 623 ± 333 s for Olig/IA (measured for RAMA37 cells). Fig. 1STIM1 translocation is induced by ATP depletion in RAMA37 and PANC1 cells. RAMA37 and PANC1 cells were transfected with STIM1-EYFP and imaged using confocal microscopy. Images of the cells just before application of inhibitors of ATP production (*t* = 0) are shown in the *left column*. *Scale bars* correspond to 5 μm. Depleting ATP with Oligomyin and 2-Deoxy-[d]{.smallcaps}-glucose (Olig/2DOG), or with Oligomyin and Iodoacetate (Olig/IA) causes STIM1-EYFP to translocate into discrete puncta in both RAMA37 (**a**--**b**), PANC1 (**c**--**d**), and HeLa (**e**--**f**) cells. Time for which cells were exposed to the inhibitors is indicated on individual images

Importantly, the process of STIM1 accumulation in puncta (with an increase of puncta fluorescence and decrease of fluorescence in regions outside the puncta) continued for a further 200--400 s after puncta formation. These results were surprising because we had anticipated that STIM1 translocation would be an active process and that it would therefore be efficiently inhibited by ATP depletion.

One of the potential consequences of ATP depletion is the depletion of phospholipids which are considered important for the targeting of STIM1 to the sub-plasmalemmal region \[[@CR19]\]. We decided to test this using RAMA37 cells transfected with a GFP-labeled PH domain of $\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$${\text{PLC}}_{\delta {\text{1}}} $$\end{document}$. We observed that Olig/IA treatment results in the slow depletion of plasma membrane-bound GFP-PH. This translocation of GFP-PH from the vicinity of the plasma membrane to the cytosol was interpreted as the depletion of PI(4,5)P~2~ \[[@CR14]\]. By the time of the first STIM1 puncta formation (approximately 600 s) the preferential sub-plasmalemmal GFP-PH localization was lost in the majority of cells (10 out of 14, Fig. [2](#Fig2){ref-type="fig"}a). Average time of the loss of preferential GFP-PH localization was 510 ± 87 s. It is clear that the Olig/IA-induced formation of the STIM1 puncta proceeds under conditions of reduced PI(4,5)P~2~.

We also conducted experiments with high concentrations of wortmannin, which were reported to inhibit store-operated Ca^2+^ influx \[[@CR6]\] and deplete PI(4)P \[[@CR6], [@CR24]\]. In our experiments, high concentrations of wortmannin (20 μM) did not produce a redistribution of GFP-PH (*n* = 8, Fig. [2](#Fig2){ref-type="fig"}b) and did not prevent formation of STIM1 puncta under conditions of Tg-induced store depletion (*n* = 24, Fig. [2](#Fig2){ref-type="fig"}c). Finally wortmannin did not inhibit STIM1 puncta formation induced by ATP depletion (*n* = 17, Fig. [2](#Fig2){ref-type="fig"}d). In these experiments, sub-plasmalemmal STIM1 puncta were present even after very prolonged treatment with wortmannin and Olig/IA (Fig. [2](#Fig2){ref-type="fig"}d). Fig. 2Effects of ATP depletion and wortmannin on PI(3,4)P~2~ content and STIM1 translocation. **a**, **b** Images of RAMA37 cells transfected with GFP-PH. Depleting ATP (**a**) with oligomyin and iodoacetate (Olig/IA) but not inhibition of PI3-kinase (b) by wortmannin (20 μM) induces GFP-PH redistribution from plasma membrane to the cytosol. **c**, **d** Images of RAMA37 cells transfected with STIM1-EYFP. Incubation of cell in wortmannin (starting 30 min before the registration and continuing through the experiment) does not prevent STIM1 translocation caused by thapsigargin (Tg) or oligomyin plus iodoacetate (Olig/IA). Time for which cells were exposed to the inhibitors is indicated on individual images. *Scale bars* correspond to 8 μm

To evaluate the time course and extent of the ATP depletion induced by the combined inhibition of oxidative phosphorylation and glycolysis, we transfected the cell lines with luciferase and measured ATP using bioluminescence. Treatment with the inhibitors induced a rapid decline of bioluminescence. Within 300--400 s after application of Olig and 2DOG (or Olig and IA), the bioluminescence recorded from RAMA37 cells became indistinguishable from the background (Fig. [3](#Fig3){ref-type="fig"}a, *n* = 7 and *n* = 14 for Olig/2DOG and Olig/IA treatment, respectively). These experiments taken together with the experiments shown in Fig. [1](#Fig1){ref-type="fig"} indicate that formation of puncta starts and progresses under conditions of severe ATP depletion. Fig. 3ATP depletion and decrease in \[Ca^2+^\]~ER~ induced by oligomycin with iodoacetate or oligomyin with 2-deoxy-[d]{.smallcaps}-glucose. Traces represent average ± SE for individual time points. **a** Luminescence measurements (photon counts normalized to initial control value) in populations of RAMA-37 cells expressing cytosolic-targeted luciferase. Changes of bioluminescence induced by oligomycin and iodoacetate (*n* = 14) are shown on (**a***a*). Results of application of oligomycin and 2-deoxyglucose (*n* = 7) are shown on (**a***b*). **b** Ratio of fluorescence of citrine (YFP) and CFP for RAMA-37 cells expressing ER-targeted cameleon D1ER. **b***a* Results of application of oligomycin and iodoacetate (*n* = 31). **b***b* shows fluorescence ratio changes due to application of oligomycin and 2-deoxyglucose (*n* = 27)

Translocation of STIM1 induced by ATP depletion is triggered by depleting the ER of Ca^2+^ {#Sec11}
------------------------------------------------------------------------------------------

At the next stage of the project, it was important to investigate if ATP depletion per se or the consequent depletion of Ca^2+^ in the ER induces the observed STIM1 translocation. These experiments were conducted on RAMA37 cells. To measure \[Ca^2+^\] in the ER (\[Ca^2+^\]~ER~) under conditions of ATP depletion, we transfected the cells with an ER-targeted low affinity calcium sensor cameleon D1ER (gift from Roger Y. Tsien, University of California at San Diego). Application of inhibitors of ATP production to RAMA37 cells triggered a very slow decline in \[Ca^2+^\]~ER~ (Fig. [3](#Fig3){ref-type="fig"}b). Most probably, the net loss of ER calcium in these conditions develops as a result of the inability of SERCA to transport Ca^2+^ into the ER. This unmasks the calcium leak which decreases \[Ca^2+^\]~ER~.

Comparison of the time required for the first puncta formation with measurements of ER calcium loss triggered by Olig/IA and Olig/2DOG (see Fig. [3](#Fig3){ref-type="fig"}b) revealed that only a small decline of \[Ca^2+^\]~ER~ can be detected by the time of the first puncta formation (corresponding to a decrease of fluorescence ratio by only 6--8%). To probe if this modest reduction of \[Ca^2+^\]~ER~ is sufficient to trigger STIM1 translocation, independently of ATP depletion, we produced graded decreases in \[Ca^2+^\]~ER~ using different concentrations of TPEN, utilizing a procedure similar to that described by Hofer and colleagues \[[@CR15]\], and studied the effects of these graded decreases on puncta formation. We observed that TPEN at the concentrations tested (0.1, 0.3, and 1 mM) produced rapidly achievable steady state levels of decreased \[Ca^2+^\]~ER~ (see Fig. [4](#Fig4){ref-type="fig"}a). The decrease of the ratio of D1ER fluorescence induced by 0.3 mM TPEN (approximately 5%) was similar to the decline observed due to inhibition of ATP production at the moment the first puncta were formed. In separate experiments, we tested the ability of TPEN (0.1--1.0 mM) to trigger puncta formation (Fig. [4](#Fig4){ref-type="fig"}b and c). After treatment with 0.1 mM TPEN (see Fig. [4](#Fig4){ref-type="fig"}b and c*b*), puncta were observed in a substantial proportion of the cells (four out of ten cells later showing responses to 1 mM TPEN). This proportion increased to 100% for 0.3 mM of TPEN (all ten cells that eventually responded to 1 mM TPEN responded to 0.3 mM as well, see Fig. [4](#Fig4){ref-type="fig"}c*c*). The density and brightness of puncta increased with further increases of the TPEN concentration (Fig. [4](#Fig4){ref-type="fig"}c*d*, c*e*). The effect of TPEN was reversible---removal of TPEN resulted in recovery of \[Ca^2+^\]~ER~ (Fig. [4](#Fig4){ref-type="fig"}a) and restoration of diffuse STIM1-YFP fluorescence (Fig. [4](#Fig4){ref-type="fig"}c*f*). Fig. 4Dose--response for TPEN-induced \[Ca^2+^\]~ER~ depletion and STIM1-EYFP translocation. **a** Ratio of fluorescence of citrine (YFP) and CFP for RAMA-37 cells expressing ER-targeted cameleon D1ER (*n* = 19). **b** Representative experiment, in which cell displayed STIM1-EYFP translocation in the presence of 0.1 mM TPEN. **c** Representative experiment, in which the *cell on the right* (*marked with arrowhead*) showed STIM1-EYFP translocation in the presence of 0.1 mM TPEN and the remaining three cells only responded to 0.3 mM TPEN. In all experiments TPEN was applied in zero-calcium extracellular solution supplemented with 0.2 mM EGTA. *Scale bars* in **b** and **c** correspond to 8 μm

Importantly, the magnitude of the \[Ca^2+^\]~ER~ decrease that resulted in puncta formation after ATP depletion also triggered puncta formation in experiments with TPEN titration (Fig. [4](#Fig4){ref-type="fig"}). This suggests that puncta formation induced by ATP depletion is explainable by the loss of \[Ca^2+^\] in the ER calcium store.

Re-translocation of STIM1 from puncta to bulk ER is an ATP-independent process {#Sec12}
------------------------------------------------------------------------------

We felt that it would be important also to investigate the ATP dependency of the re-translocation of STIM1---the process that restores the more uniform ER distribution of STIM1. Reversal of the punctuate distribution of STIM1 could be achieved after repletion of the ER calcium store. However, in the presence of Olig/2DOG or Olig/IA, we could not rely on SERCA pumps to reload Ca^2+^ into the ER, as the pumps were incapacitated by lack of ATP.

Re-translocation of STIM1 from puncta was attained using the calcium ionophore ionomycin (10 μM) with a moderate calcium concentration (0.3--0.8 mM of Ca^2+^) in the extracellular solution. We initially tested this approach on cells that had lost Ca^2+^ from the ER as a result of Tg treatment. In these experiments, Tg application triggered translocation of STIM1 to puncta (Fig. [5](#Fig5){ref-type="fig"}a), while ionomycin in combination with 0.5 mM extracellular Ca^2+^ induced re-translocation of STIM1 from a punctate to a more uniform distribution (*n* = 3). Similar phenomena were observed when ionomycin was applied in the presence of extracellular calcium after Olig/2DOG or Olig/IA incubation (Fig. [5](#Fig5){ref-type="fig"}b and c correspondingly; *n* = 6 for Olig/2DOG and n = 13 for Olig/IA). In all such experiments, we were able to attain substantial re-translocation (i.e., substantial decrease of puncta brightness and more uniform distribution of fluorescence). We were, however, limited by the time available for inducing and observing re-translocation because soon (100--400 s) after the addition of ionomycin in calcium-containing extracellular solution, the cells started to bleb. Due to this limitation, in some experiments, we observed only partial re-translocation (e.g., Fig. [5](#Fig5){ref-type="fig"}b). Changes of D1ER fluorescence ratio (Fig. [5](#Fig5){ref-type="fig"}d) reflect the loss of ER Ca^2+^ as a result of ATP depletion and further decrease of \[Ca^2+^\]~ER~ by treatment with ionomycin and calcium-free extracellular solution and increase/restoration of ER calcium content after application of ionomycin and moderate extracellular \[Ca^2+^\]. In these experiments (Fig. [5](#Fig5){ref-type="fig"}b,c), re-translocation of STIM1 from a punctate to a more uniform distribution was attained in cells that were treated by inhibitors of ATP production for more than 30 min. This strongly suggests that re-translocation of STIM1 can occur in an ATP-independent manner, and therefore, it does not require active molecular motoring. Fig. 5STIM1-EYFP translocation induced by ER calcium depletion can be reversed by ionomycin and moderate extracellular calcium. **a** The reversal of thapsigargin-induced STIM1-YFP translocation. **b** STIM1 translocation to puncta induced by ATP depletion with Oligomycin and Iodoacetate is partially reversed by ionomycin and 0.5 mM external calcium. **c** STIM1 translocation to puncta induced by ATP depletion with Oligomycin and 2-deoxy-[d]{.smallcaps}-glucose is partially reversed by ionomycin and 0.8 mM external calcium. Scale bars in (**a**), (**b**), and (**c**) correspond to 8 μm. **d** A representative cell transfected with \[Ca^2+^\]~ER~-sensitive chameleon D1ER showing changes of citrine (YFP)/CFP ratio in response to oligomycin 5 μM plus 2-deoxyglucose 10 mM and then to ionomycin plus low and high calcium

ATP depletion induces formation of co-localized puncta of STIM1 and ORAI1 {#Sec13}
-------------------------------------------------------------------------

In cells co-expressing STIM1-EYFP and ORAI1-mCherry, we observed that depletion of ATP using Olig/IA (Fig. [6](#Fig6){ref-type="fig"}, *n* = 7) or Olig/2DOG (not shown, *n* = 2) resulted in formation of STIM1 puncta which were co-localized with puncta of ORAI1. We found that out of the cell lines used in our experiments, HeLa cells were the most convenient model for such dual expression experiments. Little or no co-localization of the two constructs was observed before the inhibition of ATP production (Fig. [6](#Fig6){ref-type="fig"}a*a*--a*c*). ATP depletion resulted in formation of puncta of STIM1 accompanied with clustering of ORAI1 in the same puncta (Fig. [6](#Fig6){ref-type="fig"}b*a*--b*c* and c*a*--c*c*). Fig. 6ATP depletion induced changes in STIM1-EYFP and mCherry-Orai1 cellular localizations. **a** The *upper panel shows gray-scale images* of STIM1-EYFP (**a***a*) and mCherry-Orai1 (**a***b*) fluorescence as well as their color-coded (*green* for STIM1-EYFP and *red* for mCherry-Orai1) overlay (**a***c*). *Scale bar* corresponds to 12 μM. **b** The panel shows the corresponding images (STIM1-EYFP distribution on **b***a*, mCherry-Orai1 on **b***b*, and overlay on **b***c*) after oligomycin and iodoacetate treatment for 15 min. **c** The enlarged images of STIM1-EYFP (**c***a*), mCherry-Orai1 (**c***b*), and their overlay (**c***c*) of the area outlined as *white box* in **b***c*. **d** The profile of pixel fluorescence intensity along the white line shown on **c***c*. *Top trace* (*green*) for STIM1-EYFP and *red trace* (*bottom*) for mCherry-Orai1

ATP depletion inhibits Ca^2+^ influx induced by thapsigargin and produces very slow influx on its own in spite of prominent puncta formation {#Sec14}
--------------------------------------------------------------------------------------------------------------------------------------------

Thapsigargin treatment induced efficient store-operated Ca^2+^ entry in HeLa cells, revealed as changes of Fura-2 ratio due to addition of calcium-containing solution. The rate of the entry was three times higher in cells transfected with STIM1 and ORAI1. In Fig. [7](#Fig7){ref-type="fig"} (a*a*--b*c*), we show the normalized rate of entry (normalized by dividing individual traces by maximal average peak of ratio of Fura2 fluorescence). This allows a comparison of the responses between transfected and non-transfected cells and between different groups of measurements. The rate of calcium entry is almost unchanged between the first and the second application of calcium-containing (2 mM of Ca) extracellular solution for both transfected (Fig. [7](#Fig7){ref-type="fig"}a*a* and a*c*) and untransfected (Fig. [7](#Fig7){ref-type="fig"}b*a* and b*c*) cells. There is however a drastic inhibition of Ca^2+^ influx by Olig/IA treatment (compare the first and the second application of calcium-containing solution) for both transfected (Fig. [7](#Fig7){ref-type="fig"}a*b* and a*c*) and untransfected (Fig. [7](#Fig7){ref-type="fig"}b*b* and b*c*) cells. We also evaluated Ca^2+^ influx induced by Olig/IA treatment per se. The influx induced by Olig/IA was impossible to resolve in untransfected cells (n = 15, not shown). In cells transfected by STIM1 and Orai1, we were able to resolve Ca^2+^ influx induced by Olig/IA (see Fig. [7](#Fig7){ref-type="fig"}c*a* and c*b*). The rate of influx was approximately 12 times slower than for the influx induced by the depletion of calcium stores with thapsigargin (see Fig. [7](#Fig7){ref-type="fig"}c*b*). At the beginning of the experiments, we verified that cells were transfected with STIM1 and ORAI1, and at the end of experiments, we verified that the puncta were formed. During experiments shown on Fig. [7](#Fig7){ref-type="fig"}c, we monitored Fura Red fluorescence (which decreases with the increase of \[Ca^2+^\]). These results (Fig. [7](#Fig7){ref-type="fig"}) indicate that ATP depletion induces formation of STIM1/ORAI1 complexes which are very poor mediators of calcium influx (and even if complexes are formed by conventional store depletion with thapsigargin, subsequent ATP depletion strongly inhibits the Ca^2+^ influx). Fig. 7ATP depletion inhibits Ca^2+^ influx. (**a***a*, **a***b* and **b***a***b***b*). Ratio of Fura-2 fluorescence at 351 and 405 nm normalized by the average first peak value (produced as the result of the first addition of Ca 2 mM containing solution after the store depletion with Tg) in each population in either HeLa cells transfected with both STIM1-EYFP and mCherry-Orai1 (**a**) or untransfected HeLa cells (**b**). Traces represent average ± SE for individual time points (*n* = 10, 14, 14, and 35 for **a***a*, **a***b*, **b***a*, and **b***b*, respectively). Note that the second additions of calcium containing solution (Ca 2 mM) in (**a***b*) and (**b***b*) were done in the presence of Olig/IA. (**a***c* and **b***c*) Average and SEM for maximal first derivative of Fura-2 ratio at 351 and 405 nm excitation during the first and the second additions of 2 mM Ca^2+^ (from the traces generated by the protocols illustrated on part **a***a*, **a***b*, **b***a*, and **b***b*). The values of derivative were normalized for each cell by the average peak value of the ratio in the whole given population of cells. **c***a* Normalized fluorescence of Fura Red (excited at 488 nm) from two typical cells with Ca^2+^ stores depleted after 40 min incubation in Ca-free solution and either thapsigargin (*black trace*) or oligomycin plus iodoacetate (*gray trace*). **c***b* The calculated maximal rates of decrease of Fura Red fluorescence (from the traces generated by the protocol illustrated on part **c***a*) shown as mean ± SEM (*n* = 9 for Tg group and 11 for Olig/IA group)
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The results of this study indicate that the complete cycle of STIM1 translocation, namely, formation of puncta in the vicinity of the plasma membrane and re-translocation from puncta to the bulk ER can occur in ATP-depleted cells. This finding could have important consequences for hypoxia--reperfusion injury in a variety of tissues. After a period of hypoxia, STIM1 will be assembled into sub-plasmalemmal puncta. Even more strikingly, ATP depletion induced the formation of STIM1--ORAI1 complexes. In other words, the complete machinery for calcium influx is assembled due to energy depletion (Fig. [6](#Fig6){ref-type="fig"}). A number of studies, however, indicated that inhibition of mitochondria and/or more generally of ATP production suppressed store-operated Ca^2+^ influx \[[@CR3], [@CR9], [@CR11], [@CR16], [@CR23]\]. Our results certainly support this notion. ATP depletion produced STIM1--ORAI1 complexes and resolvable calcium influx (at least in cells transfected with both STIM1 and ORAI1), but this influx was much slower than in cells with calcium stores depleted by thapsigargin. The fact that we failed to resolve Ca^2+^ influx in untransfected cells upon ATP depletion is perhaps not surprising, as this process is expected to be much slower than thapsigargin-induced influx, and in this particular case, it is not amplified by STIM1/ORAI1 co-expression. As in previous studies \[[@CR3], [@CR9], [@CR23]\], our work indicates that ATP depletion inhibits thapsigargin-induced store-operated calcium entry. In the case of HeLa cells, inhibition was very efficient and observed in both untransfected cells and cells co-transfected with STIM1 and ORAI1. It seems therefore that cells have developed mechanisms preventing or delaying Ca^2+^ influx (and consequent calcium toxicity), and these mechanisms operate in spite of the successful assembly of STIM1--ORAI1 complexes in ATP-depleted cells. These preventative mechanisms will be investigated in further studies.

The characteristics of the ER--plasma membrane junctions necessary for STIM1 translocation to sub-plasmalemmal regions were recently discussed by Varnai and colleagues \[[@CR43]\]. In their study, chemically induced linkers were used to form PM--ER complexes. After ER Ca^2+^ depletion, STIM1 complexes were found on the periphery of junctional ER clusters. This suggests that a proportion of the structures guiding STIM1 to its sub-plasmalemmal docking stations are already preassembled. Preassembled ER--plasma membrane junctions were also described in a study by Wu and colleagues \[[@CR46]\]. Our study indicates that active transport of ER components towards the plasma membrane is not an absolute prerequisite for STIM1 translocation. We cannot exclude, of course, that some additional ER structures could be actively transported under conditions of normal energy supply.

A topic which has been vigorously discussed in the field is whether STIM1 in puncta is sub-plasmalemmal or is actually inserted into the plasma membrane \[[@CR13], [@CR46]\]. We have not addressed this question directly, but the ATP-independence of STIM1 translocation and re-translocation suggests that its movement is unlikely to be mediated by exocytic--endocytic processes.

An important question is the nature of the ATP-independent mechanism used for STIM1 translocation and the involvement of the cytoskeleton in this translocation. Recent publications characterized microtubule-dependent transport of STIM1-containing ER strands \[[@CR12], [@CR40]\]. This transport process is probably important for structuring the ER (and should depend on GTP levels and therefore on cell energetics), but it was shown to be unrelated to puncta formation \[[@CR12], [@CR40]\].

A possible explanation of the mechanism of the ATP-independent formation of STIM1 puncta comes from the study by Liou et al. \[[@CR19]\]. They propose that the mechanism of translocation involves oligomerization of STIM1 (induced by the decrease of \[Ca^2+^\]~ER~) followed by its translocation to sub-plasmalemmal puncta \[[@CR19]\]. The oligomerization unmasks a polybasic motif in the C-terminal part of STIM1, which confers on the molecule the ability to bind to plasma membrane lipids. Binding of STIM1 to the plasma membrane depletes STIM1 in the junctional ER region and induces a preferential diffusion of STIM1 oligomers from the bulk ER towards the forming puncta \[[@CR19]\]. This diffusion-based process does not necessitate direct ATP involvement. The process could be guided by the microtubular cytoskeleton \[[@CR40]\]. However, considering the outcome of previous publications \[[@CR12], [@CR40]\] and of this study, it is unlikely that it involves ATP-requiring molecular motors. The fact that the process of protein translocation involves diffusion does not a priori mean that it is ATP independent---for example, the protein may need to be phosphorylated or appropriately folded by ATP-dependent enzymes to partake in translocation.

ATP is necessary for maintaining the plasma membrane pool of phospholipids, which are considered to be important for STIM1 puncta formation \[[@CR19]\]. The changes in GFP-PH distribution, induced by Olig/IA, indicate that PI(4,5)P~2~ is usually depleted by the time of formation of the first STIM1 puncta. The rate of Olig/IA-induced PI(4,5)P~2~ depletion is relatively slow, and it is not possible to make a definitive conclusion that PI(4,5)P~2~ is not required for the STIM1 puncta formation. It is however clear that the STIM1 puncta can form in conditions of substantial depletion of PI(4,5)P~2~. Our results are in agreement with the study of Varnai and colleagues which reported that the depletion of PI(4,5)P~2~ has no effect on store-operated calcium influx \[[@CR42]\].

High concentrations of wortmannin were shown to deplete PI(4)P but not PI(4,5)P~2~ \[[@CR6], [@CR24]\]. In our experiments, wortmannin did not prevent plasma membrane GFP-PH localization. Wortmannin also did not block formation of STIM1 puncta induced by Tg or Olig/IA treatment. The presence of STIM1 puncta in cells treated for a prolonged period of time by Olig/IA and high concentrations of wortmannin suggests that PI(4)P and PI(4,5)P~2~ are not essential for the long-term maintenance of the sub-plasmalemmal puncta.

More specific tools for fast and controlled depletion of individual phospholipids should be used in further studies to investigate the importance of these molecules for STIM1 puncta formation and retention.

Direct measurements of STIM1 translocation under conditions of ATP depletion, as shown in our study, reinforce diffusional models of puncta formation and specify that both translocation to puncta and re-translocation from puncta to the bulk of the ER are ATP-independent processes.
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Olig

:   Oligomycin

IA

:   Iodoacetate

2DOG

:   2-Deoxyglucose

Rot

:   Rotenone

STIM1

:   Stromal interacting molecule one

Tg

:   Thapsigargin

TPEN

:   *N*,*N*,*N*′,*N*′-Tetrakis(2-pyridylmethyl)ethylenediamine

GFP-PH

:   Pleckstrin homology domain of plospholipase C~δ1~ labeled with enhanced green fluorescent protein

PI(4)P

:   Phosphatidylinositol 4-phosphate

PI(4,5)P~2~

:   Phosphatidylinositol 4,5-bisphosphate

Wort

:   Wortmannin

Michael Chvanov and Ciara M. Walsh are considered as equal first authors.
